15.27 USD
-0.11 (-0.72%)
15.27 USD
0 (0%)
Taking everything into account, OPRX scores 6 out of 10 in our fundamental rating. OPRX was compared to 35 industry peers in the Health Care Technology industry. OPRX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. OPRX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
OPRX had positive earnings in the past year.
OPRX had a positive operating cash flow in the past year.
In the past 5 years OPRX reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: OPRX reported negative operating cash flow in multiple years.
1.2 Ratios
OPRX's Return On Assets of 0.02% is fine compared to the rest of the industry. OPRX outperforms 74.29% of its industry peers.
Looking at the Return On Equity, with a value of 0.03%, OPRX is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
OPRX has a better Return On Invested Capital (3.51%) than 77.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.02% | ||
| ROE | 0.03% | ||
| ROIC | 3.51% |
ROA(3y)-9.94%
ROA(5y)-6.64%
ROE(3y)-13.38%
ROE(5y)-8.85%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OPRX has a better Profit Margin (0.03%) than 74.29% of its industry peers.
With a decent Operating Margin value of 6.17%, OPRX is doing good in the industry, outperforming 71.43% of the companies in the same industry.
OPRX has a Gross Margin (65.31%) which is in line with its industry peers.
OPRX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.17% | ||
| PM (TTM) | 0.03% | ||
| GM | 65.31% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.49%
GM growth 5Y0.53%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so OPRX is destroying value.
The number of shares outstanding for OPRX has been increased compared to 1 year ago.
OPRX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for OPRX has been reduced compared to a year ago.
2.2 Solvency
OPRX has an Altman-Z score of 3.91. This indicates that OPRX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of OPRX (3.91) is better than 77.14% of its industry peers.
OPRX has a debt to FCF ratio of 2.43. This is a good value and a sign of high solvency as OPRX would need 2.43 years to pay back of all of its debts.
OPRX has a Debt to FCF ratio of 2.43. This is in the better half of the industry: OPRX outperforms 74.29% of its industry peers.
OPRX has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
OPRX has a Debt to Equity ratio of 0.20. This is comparable to the rest of the industry: OPRX outperforms 48.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 2.43 | ||
| Altman-Z | 3.91 |
ROIC/WACC0.32
WACC11.1%
2.3 Liquidity
OPRX has a Current Ratio of 3.05. This indicates that OPRX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.05, OPRX is in the better half of the industry, outperforming 62.86% of the companies in the same industry.
A Quick Ratio of 3.05 indicates that OPRX has no problem at all paying its short term obligations.
OPRX's Quick ratio of 3.05 is fine compared to the rest of the industry. OPRX outperforms 68.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.05 | ||
| Quick Ratio | 3.05 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 182.76% over the past year.
Measured over the past years, OPRX shows a very strong growth in Earnings Per Share. The EPS has been growing by 101.23% on average per year.
OPRX shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.18%.
OPRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.22% yearly.
EPS 1Y (TTM)182.76%
EPS 3Y-9.14%
EPS 5Y101.23%
EPS Q2Q%66.67%
Revenue 1Y (TTM)24.18%
Revenue growth 3Y14.55%
Revenue growth 5Y30.22%
Sales Q2Q%22.33%
3.2 Future
Based on estimates for the next years, OPRX will show a very strong growth in Earnings Per Share. The EPS will grow by 51.28% on average per year.
Based on estimates for the next years, OPRX will show a quite strong growth in Revenue. The Revenue will grow by 11.21% on average per year.
EPS Next Y105.03%
EPS Next 2Y53.84%
EPS Next 3Y51.28%
EPS Next 5YN/A
Revenue Next Year18.13%
Revenue Next 2Y14.46%
Revenue Next 3Y11.21%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 18.62 indicates a rather expensive valuation of OPRX.
OPRX's Price/Earnings ratio is rather cheap when compared to the industry. OPRX is cheaper than 88.57% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.31, OPRX is valued a bit cheaper.
With a Price/Forward Earnings ratio of 19.55, OPRX is valued on the expensive side.
OPRX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. OPRX is cheaper than 80.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.59. OPRX is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.62 | ||
| Fwd PE | 19.55 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OPRX indicates a somewhat cheap valuation: OPRX is cheaper than 65.71% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, OPRX is valued cheaply inside the industry as 82.86% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.51 | ||
| EV/EBITDA | 26.52 |
4.3 Compensation for Growth
OPRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OPRX's earnings are expected to grow with 51.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.18
PEG (5Y)0.18
EPS Next 2Y53.84%
EPS Next 3Y51.28%
5. Dividend
5.1 Amount
No dividends for OPRX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
15.27
-0.11 (-0.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners71.3%
Inst Owner Change5.23%
Ins Owners12.48%
Ins Owner Change1.93%
Market Cap283.56M
Revenue(TTM)109.51M
Net Income(TTM)32.00K
Analysts83.08
Price Target24.82 (62.54%)
Short Float %11.29%
Short Ratio5.24
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)807.75%
Min EPS beat(2)342.72%
Max EPS beat(2)1272.78%
EPS beat(4)4
Avg EPS beat(4)447.32%
Min EPS beat(4)8.43%
Max EPS beat(4)1272.78%
EPS beat(8)7
Avg EPS beat(8)250.62%
EPS beat(12)10
Avg EPS beat(12)191.95%
EPS beat(16)13
Avg EPS beat(16)147.27%
Revenue beat(2)2
Avg Revenue beat(2)17.89%
Min Revenue beat(2)7.23%
Max Revenue beat(2)28.56%
Revenue beat(4)4
Avg Revenue beat(4)13.8%
Min Revenue beat(4)4.37%
Max Revenue beat(4)28.56%
Revenue beat(8)6
Avg Revenue beat(8)4.84%
Revenue beat(12)8
Avg Revenue beat(12)2.3%
Revenue beat(16)8
Avg Revenue beat(16)0.32%
PT rev (1m)28.07%
PT rev (3m)28.07%
EPS NQ rev (1m)-15.31%
EPS NQ rev (3m)-16.07%
EPS NY rev (1m)0%
EPS NY rev (3m)4.74%
Revenue NQ rev (1m)-2.64%
Revenue NQ rev (3m)-2.64%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.62 | ||
| Fwd PE | 19.55 | ||
| P/S | 2.59 | ||
| P/FCF | 24.51 | ||
| P/OCF | 23.98 | ||
| P/B | 2.32 | ||
| P/tB | 31.66 | ||
| EV/EBITDA | 26.52 |
EPS(TTM)0.82
EY5.37%
EPS(NY)0.78
Fwd EY5.11%
FCF(TTM)0.62
FCFY4.08%
OCF(TTM)0.64
OCFY4.17%
SpS5.9
BVpS6.58
TBVpS0.48
PEG (NY)0.18
PEG (5Y)0.18
Graham Number11.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.02% | ||
| ROE | 0.03% | ||
| ROCE | 4.45% | ||
| ROIC | 3.51% | ||
| ROICexc | 4.03% | ||
| ROICexgc | 28.04% | ||
| OM | 6.17% | ||
| PM (TTM) | 0.03% | ||
| GM | 65.31% | ||
| FCFM | 10.56% |
ROA(3y)-9.94%
ROA(5y)-6.64%
ROE(3y)-13.38%
ROE(5y)-8.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.49%
GM growth 5Y0.53%
F-Score7
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 2.43 | ||
| Debt/EBITDA | 2.24 | ||
| Cap/Depr | 5.95% | ||
| Cap/Sales | 0.24% | ||
| Interest Coverage | 1.25 | ||
| Cash Conversion | 106.61% | ||
| Profit Quality | 36153.1% | ||
| Current Ratio | 3.05 | ||
| Quick Ratio | 3.05 | ||
| Altman-Z | 3.91 |
F-Score7
WACC11.1%
ROIC/WACC0.32
Cap/Depr(3y)19.52%
Cap/Depr(5y)17.6%
Cap/Sales(3y)0.7%
Cap/Sales(5y)0.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)182.76%
EPS 3Y-9.14%
EPS 5Y101.23%
EPS Q2Q%66.67%
EPS Next Y105.03%
EPS Next 2Y53.84%
EPS Next 3Y51.28%
EPS Next 5YN/A
Revenue 1Y (TTM)24.18%
Revenue growth 3Y14.55%
Revenue growth 5Y30.22%
Sales Q2Q%22.33%
Revenue Next Year18.13%
Revenue Next 2Y14.46%
Revenue Next 3Y11.21%
Revenue Next 5YN/A
EBIT growth 1Y156.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year204.28%
EBIT Next 3Y50.99%
EBIT Next 5YN/A
FCF growth 1Y115790%
FCF growth 3Y154.28%
FCF growth 5YN/A
OCF growth 1Y549.84%
OCF growth 3Y88.49%
OCF growth 5YN/A
OPTIMIZERX CORP / OPRX FAQ
What is the ChartMill fundamental rating of OPTIMIZERX CORP (OPRX) stock?
ChartMill assigns a fundamental rating of 6 / 10 to OPRX.
What is the valuation status for OPRX stock?
ChartMill assigns a valuation rating of 6 / 10 to OPTIMIZERX CORP (OPRX). This can be considered as Fairly Valued.
Can you provide the profitability details for OPTIMIZERX CORP?
OPTIMIZERX CORP (OPRX) has a profitability rating of 4 / 10.
What is the valuation of OPTIMIZERX CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for OPTIMIZERX CORP (OPRX) is 18.62 and the Price/Book (PB) ratio is 2.32.
Can you provide the expected EPS growth for OPRX stock?
The Earnings per Share (EPS) of OPTIMIZERX CORP (OPRX) is expected to grow by 105.03% in the next year.